Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4644395
Max Phase: Preclinical
Molecular Formula: C30H39Cl2F3N6O5S
Molecular Weight: 650.72
Molecule Type: Unknown
Associated Items:
ID: ALA4644395
Max Phase: Preclinical
Molecular Formula: C30H39Cl2F3N6O5S
Molecular Weight: 650.72
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COCCN(Cc1sc(NC(=O)c2cnc(N3CCC(C(=O)O)CC3)cn2)nc1-c1ccc(OC)c(C(F)(F)F)c1)CC(C)C.Cl.Cl
Standard InChI: InChI=1S/C30H37F3N6O5S.2ClH/c1-18(2)16-38(11-12-43-3)17-24-26(20-5-6-23(44-4)21(13-20)30(31,32)33)36-29(45-24)37-27(40)22-14-35-25(15-34-22)39-9-7-19(8-10-39)28(41)42;;/h5-6,13-15,18-19H,7-12,16-17H2,1-4H3,(H,41,42)(H,36,37,40);2*1H
Standard InChI Key: LVSVXTLVISJRCA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 650.72 | Molecular Weight (Monoisotopic): 650.2498 | AlogP: 5.29 | #Rotatable Bonds: 13 |
Polar Surface Area: 130.01 | Molecular Species: ACID | HBA: 10 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.54 | CX Basic pKa: 8.40 | CX LogP: 2.43 | CX LogD: 2.39 |
Aromatic Rings: 3 | Heavy Atoms: 45 | QED Weighted: 0.25 | Np Likeness Score: -1.77 |
1. Tanaka H, Negoro K, Koike T, Tsukamoto I, Yokoyama K, Maeda J, Inagaki Y, Shimoshige Y, Ino K, Ishizu K, Takahashi T.. (2020) Discovery and structure-activity relationships study of positive allosteric modulators of the M3 muscarinic acetylcholine receptor., 28 (13): [PMID:32386953] [10.1016/j.bmc.2020.115531] |
Source(1):